Cardiovascular risk in diabetic women Chara BolegoAndrea PoliRodolfo Paoletti Invited Commentary Pages: 79 - 81
Clinical trials of vitamin E in coronary artery disease: Is it time to reconsider the low-density lipoprotein oxidation hypothesis? Jay W. Heinecke Invited Commentary Pages: 83 - 87
C-reactive protein: The pawn has been promoted to queen Edward T. H. YehRobert P. Palusinski OriginalPaper Pages: 101 - 105
Lipoprotein(a) and the atherothrombotic process: Mechanistic insights and clinical implications Angelo M. Scanu OriginalPaper Pages: 106 - 113
Cyclooxygenase-2 inhibitors: Is there an association with coronary or renal events? Richard J. Bing OriginalPaper Pages: 114 - 117
Aggressive medical management of coronary artery disease versus mechanical revascularization Elaine ChiquetteRobert Chilton OriginalPaper Pages: 118 - 123
The renin-angiotensin-aldosterone system as a target in coronary disease James H. O’KeefeJared T. LurkJanet A. Haskin OriginalPaper Pages: 124 - 130
Uncontrolled hypertension as a risk for coronary artery disease: Patient characteristics and the role of physician intervention David J. HymanValory N. Pavlik OriginalPaper Pages: 131 - 138
The role of omega-3 fatty acids in cardiovascular disease Clemens von Schacky OriginalPaper Pages: 139 - 145
Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination David G. Meyers OriginalPaper Pages: 146 - 149
Coronary arterial remodeling: From bench to bedside Paul SchoenhagenSteven E. NissenE. Murat Tuzcu OriginalPaper Pages: 150 - 154
